Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy

Open Forum Infectious Diseases
Priya BhagwatJudith S Currier

Abstract

Racial/ethnic disparities in HIV outcomes have persisted despite effective antiretroviral therapy. In a study of initial regimens, we found viral suppression varied by race/ethnicity. In this exploratory analysis, we use clinical and socioeconomic data to assess factors associated with virologic failure and adverse events within racial/ethnic groups. Data were from AIDS Clinical Trial Group A5257, a randomized trial of initial regimens with either atazanavir/ritonavir, darunavir/ritonavir, or raltegravir (each combined with tenofovir DF and emtricitabine). We grouped participants by race/ethnicity and then used Cox-proportional hazards regression to examine the impact of demographic, clinical, and socioeconomic factors on the time to virologic suppression and time to adverse event reporting within each racial/ethnic group. We analyzed data from 1762 participants: 757 self-reported as non-Hispanic black (NHB), 615 as non-Hispanic white (NHW), and 390 as Hispanic. The proportion with virologic failure was higher for NHB (22%) and Hispanic (17%) participants compared with NHWs (9%). Factors associated with virologic failure were poor adherence and higher baseline HIV RNA level. Prior clinical AIDS diagnosis was associated with vir...Continue Reading

References

Nov 28, 2001·JAMA : the Journal of the American Medical Association·A N PhillipsUNKNOWN EuroSIDA Study Group
Oct 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Suely H TuboiMauro Schechter
Jul 1, 2006·Journal of General Internal Medicine·Mary Catherine BeachRichard D Moore
Jan 8, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ellen M TedaldiMary van den Berg-Wolf
Apr 1, 2008·AIDS Patient Care and STDs·Frank H GalvanEric G Bing
Apr 21, 2010·American Journal of Public Health·Marcie S RubinBruce G Link
Jul 14, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Debika BhattacharyaJ S Currier
Nov 18, 2011·Southern Medical Journal·Christine U OramasionwuChristopher R Frei
Jul 3, 2013·Clinical Interventions in Aging·Lauren J GleasonKrupa Shah
Sep 21, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather J RibaudoRoy M Gulick
Apr 26, 2014·Social Work Research·Tara R EarlSomnath Saha

❮ Previous
Next ❯

Software Mentioned

SAS
SAS System

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Weiwei MuTREAT Asia Pediatric HIV Observational Database of IeDEA Asia-Pacific
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Heather J RibaudoRoy M Gulick
© 2022 Meta ULC. All rights reserved